| Financial Year |
March 31 2023 |
| Monetary Funds |
539,898,876.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
69,367,358.13 |
| Advances to Suppliers |
5,105,941.91 |
| Other Receivables |
3,292,278.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
559,326.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,148,093.55 |
| Total Current Assets |
900,648,024.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,981,640.92 |
| Investment Properties |
54,182,263.50 |
| Fixed Assetes |
15,118,056,242.77 |
| Under-construction Projects |
431,821,459.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,503,222.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
27,088,953.93 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
15,831,660,946.85 |
| Total Assets |
16,732,308,971.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
413,517,749.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,452,741.64 |
| Taxes Payable |
226,847,101.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,676,939.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,625,778,031.50 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,371,272,563.53 |
| Long-term Loans |
7,416,413,076.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
388,584,350.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,118,732.59 |
| Deferred Income Tax Liabilities |
20,693,153.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,961,503,175.20 |
| Total Liabilities |
10,332,775,738.73 |
| Paid-In Capital(Or Share Stock) |
427,558,126.00 |
| Capital Surplus |
1,021,698,381.50 |
| Surplus Reserve |
270,058,217.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,937,478,111.98 |
| Minority Stockholder's Interest |
2,735,177,702.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,664,355,530.50 |
| Owner's Equity（Stockholder's Equity） |
6,399,533,232.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,732,308,971.68 |
